Source: The Wall Street Journal By AUSTEN HUFFORD Updated March 30, 2016 11:45 a.m. ET Valeant Pharmaceuticals International Inc. sought some room to maneuver Wednesday, asking its lenders to relax some debt-covenant terms and give it an additional month to file its delayed annual report. The Canadian drug company said…...
Anacor Pharmaceuticals Announces Late-Breaking Oral Presentation of Crisaborole Topical Ointment, 2% Phase 3 Pivotal Data
Source: Anacor Pharmaceuticals, Inc. (ANAC) announced today that data from its Phase 3 pivotal studies of investigational drug crisaborole topical ointment, 2% will be presented at the 74th Annual Meeting of the American Academy of Dermatology in Washington, D.C. “Crisaborole Topical Ointment, 2%: a Novel, Nonsteroidal, Topical Anti-Inflammatory, Phosphodiesterase 4…...